1 History and development
Blood banking developed in response to the growing medical need for reliable transfusion support. Its history reflects advances in physiology, laboratory science, refrigeration, and public health organization. Over time, blood collection moved from occasional direct donation to a coordinated system based on testing, processing, storage, and distribution.
1.1 Early blood transfusion practices
Early transfusion attempts were limited by poor understanding of blood compatibility and by the lack of effective anticoagulants and storage methods. In many cases, transfusions were performed directly from donor to recipient, often during surgery or in emergencies. These procedures were difficult to standardize and carried substantial risk.
1.2 Emergence of organized blood banking
The development of blood typing and improved transfusion techniques made it possible to create organized systems for collecting and supplying blood. During the early 20th century, clinicians and researchers established the first practical methods for storing blood for short periods and coordinating donor access. This shift laid the foundation for blood banks as specialized medical facilities.
1.3 Advances in blood storage and component therapy
Mid-20th-century innovations made it possible to separate whole blood into components suited to different clinical needs. Refrigeration, anticoagulant-preservative solutions, and plastic collection bags improved storage and handling. Component therapy increased efficiency by allowing one donation to support multiple patients, such as by providing red cells, platelets, or plasma separately.
1.4 Modern blood banking systems
Contemporary blood banking relies on standardized testing, computerized record keeping, and regulated supply chains. Many systems now coordinate donations across hospitals, regional centers, and national networks. Modern practice emphasizes safety, traceability, and efficient matching of blood products to patient needs.
2 Organization and structure
Blood banking services are organized in different ways depending on population size, healthcare infrastructure, and local demand. Some facilities focus on hospital supply, while others manage collection and distribution for larger regions. Together, these systems support routine care and emergency response.
2.1 Hospital-based blood banks
Hospital-based blood banks primarily serve patients within a single medical center or hospital network. They often maintain a limited inventory for urgent transfusion needs and perform compatibility testing for inpatients and surgical cases. These units may also coordinate with external suppliers when demand exceeds local stock.
2.2 Community and regional blood centers
Community and regional blood centers collect donations from volunteer donors and distribute products to multiple hospitals. They often manage donor recruitment, testing, component preparation, and inventory allocation on a larger scale. Regional coordination helps balance supply and demand across different facilities.
2.3 Mobile collection units
Mobile collection units bring donation services to workplaces, schools, community centers, and other accessible locations. They are used to increase donor participation and extend collection capacity beyond fixed sites. These units follow the same safety and testing standards as permanent collection centers.
2.4 National and international blood services
In some countries, national blood services oversee collection standards, distribution policies, and supply planning across broad areas. International cooperation may support disaster response, technical training, and product exchange in special circumstances. Such systems help stabilize supplies and promote consistent quality.
3 Blood collection
Blood collection is the first step in the transfusion supply chain. It requires donor recruitment, health screening, and controlled collection procedures to protect both donors and recipients. The type of donation selected depends on medical need and donor suitability.
3.1 Donor recruitment
Donor recruitment aims to maintain a steady and diverse supply of blood donors. Outreach efforts often emphasize regular donation, appointment scheduling, and awareness of seasonal shortages. Effective recruitment helps ensure that blood products are available when demand increases.
3.2 Donor eligibility screening
Before donation, individuals are screened for age, weight, health status, recent travel, medications, and risk factors that may affect safety. Screening also includes brief medical history questions and checks for temporary deferrals. These measures reduce the chance of harm to the donor and improve product safety.
3.3 Whole blood donation
Whole blood donation collects blood in a single session, typically into a sterile bag containing anticoagulant. The donation is then processed into components for different clinical uses. This method remains widely used because it is efficient and broadly applicable.
3.4 Apheresis donation
Apheresis is a collection method in which blood is withdrawn, one or more components are separated by machine, and the remaining blood is returned to the donor. It allows targeted collection of specific products in larger quantities than whole blood donation. The procedure is used when certain components are needed in concentrated form.
3.4.1 Plateletpheresis
Plateletpheresis collects platelets directly from a donor through an apheresis device. This approach can yield a larger platelet dose from a single donor than pooled whole-blood-derived platelets. It is valuable for patients requiring repeated platelet support.
3.4.2 Plasmapheresis
Plasmapheresis collects plasma while returning cellular components to the donor. The recovered plasma may be used for transfusion or further fractionation into therapeutic products. This method is also important for donors who are eligible to give plasma more frequently than whole blood.
3.4.3 Red cell apheresis
Red cell apheresis selectively collects red blood cells and returns the remaining blood components. It can be used to obtain one or two units from a suitable donor in a controlled manner. This method is less common than whole blood donation but useful in specific settings.
4 Testing and processing
After collection, blood undergoes laboratory testing and processing before release for clinical use. These steps identify blood type, detect infectious risks, and prepare products in forms appropriate for transfusion. Careful processing supports both safety and efficient use of donated blood.
4.1 Blood group typing
Blood group typing determines the ABO group and Rh status of the donor unit. This information is essential for matching blood to recipients and preventing severe incompatibility reactions. Additional typing may be performed for other clinically important antigens.
4.2 Antibody screening
Antibody screening checks donor or recipient samples for unexpected red cell antibodies. In recipients, this helps identify potential compatibility problems before transfusion. In donor testing workflows, related methods support safe crossmatching and product assignment.
4.3 Infectious disease testing
All donated blood is screened for infectious agents that could be transmitted through transfusion. Testing panels vary by region but commonly include assays for viral and, in some settings, bacterial or parasitic risks. Positive or indeterminate results lead to unit discard and donor follow-up according to protocol.
4.4 Component separation
Component separation divides whole blood into distinct products so each can be used for a specific indication. Separation is usually performed by centrifugation and controlled expression into satellite containers. This process increases the clinical usefulness of each donation.
4.4.1 Red blood cells
Red blood cells are prepared for patients who need oxygen-carrying support, such as those with anemia, blood loss, or certain chronic disorders. They are usually stored refrigerated and administered through standard transfusion procedures. Their use is one of the most common applications of blood banking.
4.4.2 Platelets
Platelets are prepared for patients with thrombocytopenia or platelet dysfunction. Because platelets have a short shelf life and require room-temperature storage, they present special inventory challenges. They are often supplied close to the time of clinical need.
4.4.3 Plasma
Plasma contains clotting factors and other proteins useful in transfusion and fractionation. It may be frozen soon after collection to preserve labile components. In clinical practice, plasma is used for selected bleeding or coagulation disorders.
4.5 Pathogen reduction methods
Pathogen reduction methods are designed to lower the risk of transfusion-transmitted infection in certain components, especially plasma and platelets. These systems use chemical or physical treatment to inactivate a range of microorganisms. They complement, rather than replace, donor screening and laboratory testing.
5 Storage and inventory management
Blood products have limited shelf lives and specific storage requirements. Blood banks must monitor temperature, expiration dates, and demand patterns to avoid waste and shortages. Inventory management is therefore central to day-to-day operations.
5.1 Temperature requirements
Different blood components require different storage conditions. Red cells are typically refrigerated, platelets are kept at controlled room temperature with agitation, and plasma is stored frozen. Maintaining correct temperatures preserves product quality and safety.
5.2 Shelf life of blood products
Shelf life varies by component and by preservation method. Red cells generally last longer than platelets, while frozen plasma may be stored for extended periods. Limited shelf life makes rotation and forecasting important for avoiding unnecessary discards.
5.3 Stock rotation and traceability
Stock rotation ensures that older units are used before newer ones when appropriate. Traceability systems track each unit from donation to transfusion or disposal. These records support recalls, audits, and investigations when needed.
5.4 Emergency reserves and shortages
Blood banks often maintain emergency reserves for trauma, surgery, and disaster response. Shortages can occur during holidays, outbreaks, weather disruptions, or sudden increases in demand. Contingency planning helps prioritize critical use and reduce service interruption.
6 Compatibility and transfusion support
Compatibility procedures help match blood products to patients safely and effectively. Blood banks also provide guidance on special products and manage adverse events related to transfusion. These services are closely linked to clinical decision-making.
6.1 Crossmatching
Crossmatching is a laboratory test that checks whether donor red cells are compatible with a recipient’s plasma. It is used to reduce the risk of hemolytic transfusion reactions. In urgent settings, expedited methods may be used according to established protocols.
6.2 Transfusion indications
Transfusion indications are the clinical reasons a patient may receive blood or a component. Common examples include acute blood loss, severe anemia, bleeding disorders, and hematologic treatments. Decisions are based on laboratory values, symptoms, and overall clinical status.
6.3 Special blood products
Special blood products are modified to meet the needs of specific patient groups or to reduce certain risks. These preparations are used in hematology, oncology, neonatal care, and other specialized settings. They are typically ordered when standard products are not sufficient.
6.3.1 Irradiated blood
Irradiated blood has been exposed to radiation to prevent transfusion-associated graft-versus-host disease. It is used for patients at increased risk because of immune suppression or particular clinical conditions. The treatment does not replace compatibility testing.
6.3.2 Leukoreduced blood
Leukoreduced blood has most white blood cells removed before transfusion. This process can reduce febrile reactions and lower the risk of certain complications linked to donor leukocytes. It is widely used in many transfusion systems.
6.3.3 Washed components
Washed components are processed to remove much of the plasma and residual additives. They are used when a patient has severe allergic reactions or other sensitivities to transfused material. Washing can shorten shelf life and requires additional processing.
6.4 Management of transfusion reactions
Transfusion reactions are evaluated by stopping the transfusion, assessing the patient, and investigating the implicated unit. Reactions may range from mild allergic responses to more serious hemolytic or febrile events. Blood banks collaborate with clinical teams to identify causes and prevent recurrence.
7 Safety and quality control
Safety and quality control are essential to every stage of blood banking. Facilities use standardized procedures, trained personnel, and documentation systems to minimize risk. Continuous oversight helps ensure that blood products meet medical and regulatory expectations.
7.1 Donor and recipient safety
Safety practices protect donors from adverse effects and recipients from contaminated or incompatible products. Donors are monitored during and after collection for signs of fainting, bruising, or other complications. Recipient safety depends on accurate identification, testing, and administration procedures.
7.2 Sterile collection and handling
Sterile collection begins with single-use needles, sealed collection bags, and antiseptic skin preparation. Proper handling prevents contamination during collection, processing, and storage. Maintaining cleanliness is especially important for components stored at room temperature.
7.3 Quality assurance programs
Quality assurance programs review equipment performance, staff training, test accuracy, and process consistency. They include internal checks, documentation reviews, and corrective actions when problems are found. Such programs help maintain reliable service over time.
7.4 Regulatory compliance and accreditation
Blood banks operate under laws, standards, and inspection systems that vary by country. Accreditation may require adherence to detailed procedures for testing, storage, labeling, and reporting. Compliance helps assure hospitals and patients that blood products are managed responsibly.
8 Ethics and public health
Blood banking has important ethical and public health dimensions because it depends on donors, serves diverse patient populations, and must maintain public trust. Policies often focus on fairness, transparency, and sustainable supply. Public communication also plays a major role in maintaining donation levels.
8.1 Voluntary donation systems
Voluntary donation systems rely on unpaid donors who give blood for the benefit of others. Many blood services favor voluntary donation because it supports public trust and stable supply. Regular donation campaigns encourage repeat participation without coercion.
8.2 Confidentiality and informed consent
Donors should receive clear information about the donation process, possible risks, and how their blood will be used. Personal and medical information must be handled confidentially. Informed consent supports ethical collection and respects donor autonomy.
8.3 Blood supply planning
Blood supply planning uses demand forecasting, inventory data, and seasonal patterns to anticipate need. Planning helps prevent shortages of commonly used components and supports emergency preparedness. Coordination across facilities can improve resilience during periods of high demand.
8.4 Public education and donor outreach
Public education promotes understanding of donation eligibility, safety, and the importance of regular giving. Outreach efforts may include media campaigns, community events, and partnerships with institutions. Clear information can reduce hesitation and broaden the donor base.